BioSpace News Archive

Cold Spring Harbor Laboratory President and CEO Bruce Stillman has been dissecting DNA replication, a critical step in cell division, since the 1980s.

Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today reports its Q4 and full year 2020 financial results and provides a business update.

Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsized, full-service contract research organization (CRO), announced today that Sherilyn Adcock, RPH, PHD, has been promoted to chief scientific officer, Early Phase Development.

Afecta Pharmaceuticals, a company focused on developing drugs that modulate key pathways that drive disease processes associated with immune disorders, neurological dysfunction and cancers, announced that the United States Patent and Trademark Office has granted a patent on March 9, 2021 for a class of novel compounds that inhibit the CCL5/RANTES pathway.

The Benzinga Biotech Small Cap Conference will be taking place from March 24-25, 2021.

Tampa General Hospital, working with USF Health, is one of the first sites in the country – and the first in Florida – to enroll patients in a new national study testing whether a minimally invasive procedure can safely and effectively treat subacute and chronic subdural hematomas, a common type of brain bleed.

The American Diabetes Association® and Beyond Type 1 unveil the ADA X BT1 Collab

Pfizer Inc. (NYSE: PFE) announced today that it is progressing to multiple ascending doses after completing the dosing of single ascending doses in a Phase 1 study in healthy adults to evaluate the safety and tolerability of an investigational, novel oral antiviral therapeutic for SARS-CoV-2, the virus that causes COVID-19.

Today Genomind made two major leadership announcements. Cynthia Kilroy has joined the company as Chief Strategy & Corporate Development Officer and a member of the Genomind Executive Team. And Stephen R. Saklad, PharmD, BCCP, is joining the company’s Scientific Advisory Board (SAB).

Stella Diagnostics, Inc . announced today that the Companys Chief Executive Officer, Dr. Joe Abdo, will participate in the Benzinga Biotech Small Cap Conference to be held virtually March 24-25, 2021.